Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 86Recurrence 14Neoplasms, Plasma Cell 14Lymphoma, Non-Hodgkin 9Lymphoma 7Leukemia, Plasma Cell 6Immunoglobulin Light-chain Amyloidosis 5Smoldering Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Primary Myelofibrosis 2POEMS Syndrome 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hodgkin Disease 2Hematologic Neoplasms 2Fasting 2Burkitt Lymphoma 2Alzheimer Disease 2Waldenstrom Macroglobulinemia 1Vomiting 1Vitamin D Deficiency 1Thrombocythemia, Essential 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Fasting × Plasma cell × Clear all
NCT04617704 2021-09-22

BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Unknown
15 enrolled
Plasma cell

Fasting, Multiple Myeloma

NCT04236011 2021-06-15

BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Unknown
15 enrolled
Plasma cell

Fasting, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡